IL120988A0 - Ortho-substituded benzoylguenidines process for their preparation their use as a medicament comprising them - Google Patents

Ortho-substituded benzoylguenidines process for their preparation their use as a medicament comprising them

Info

Publication number
IL120988A0
IL120988A0 IL12098897A IL12098897A IL120988A0 IL 120988 A0 IL120988 A0 IL 120988A0 IL 12098897 A IL12098897 A IL 12098897A IL 12098897 A IL12098897 A IL 12098897A IL 120988 A0 IL120988 A0 IL 120988A0
Authority
IL
Israel
Prior art keywords
benzoylguenidines
substituded
ortho
medicament
preparation
Prior art date
Application number
IL12098897A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL120988A0 publication Critical patent/IL120988A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
IL12098897A 1996-06-04 1997-06-03 Ortho-substituded benzoylguenidines process for their preparation their use as a medicament comprising them IL120988A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19622370A DE19622370A1 (de) 1996-06-04 1996-06-04 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
IL120988A0 true IL120988A0 (en) 1997-11-20

Family

ID=7796095

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12098897A IL120988A0 (en) 1996-06-04 1997-06-03 Ortho-substituded benzoylguenidines process for their preparation their use as a medicament comprising them

Country Status (29)

Country Link
US (1) US6011063A (ja)
EP (1) EP0811610B1 (ja)
JP (1) JP4101904B2 (ja)
KR (1) KR980002019A (ja)
CN (1) CN1064956C (ja)
AR (1) AR008761A1 (ja)
AT (1) ATE209630T1 (ja)
AU (1) AU723665B2 (ja)
BR (1) BR9703440A (ja)
CA (1) CA2206758C (ja)
CZ (1) CZ289411B6 (ja)
DE (2) DE19622370A1 (ja)
DK (1) DK0811610T3 (ja)
ES (1) ES2166487T3 (ja)
HR (1) HRP970304B1 (ja)
HU (1) HUP9700989A3 (ja)
ID (1) ID17038A (ja)
IL (1) IL120988A0 (ja)
MX (1) MX9704094A (ja)
NO (1) NO310188B1 (ja)
NZ (1) NZ314973A (ja)
PL (1) PL185757B1 (ja)
PT (1) PT811610E (ja)
RU (1) RU2214397C2 (ja)
SI (1) SI0811610T1 (ja)
SK (1) SK282628B6 (ja)
TR (1) TR199700453A2 (ja)
TW (1) TW429243B (ja)
ZA (1) ZA974869B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410563B1 (en) 1999-12-22 2002-06-25 Merck Frosst Canada & Co. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
MY123585A (en) 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
WO2001090076A1 (en) 2000-05-25 2001-11-29 Merck Frosst Canada & Co. Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
US6740666B2 (en) 2000-12-20 2004-05-25 Merck & Co., Inc. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
JP4460221B2 (ja) 2001-05-24 2010-05-12 メルク フロスト カナダ リミテツド １−ビアリール−１，８−ナフチリジン−４−オン系ホスホジエステラーゼ−４阻害薬
JO2311B1 (en) 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyl inhibitors Ariel phosphodiesterase-4
ATE486600T1 (de) 2002-03-12 2010-11-15 Merck Sharp & Dohme Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE157351T1 (de) * 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
DE19622370A1 (de) 1997-12-11
EP0811610A1 (de) 1997-12-10
SI0811610T1 (en) 2002-04-30
AU2465097A (en) 1997-12-11
US6011063A (en) 2000-01-04
HRP970304A2 (en) 1998-04-30
NZ314973A (en) 1998-09-24
MX9704094A (es) 1997-12-31
TW429243B (en) 2001-04-11
HRP970304B1 (en) 2002-10-31
CN1175572A (zh) 1998-03-11
HUP9700989A3 (en) 1998-04-28
CZ289411B6 (cs) 2002-01-16
PT811610E (pt) 2002-05-31
KR980002019A (ko) 1998-03-30
CN1064956C (zh) 2001-04-25
ID17038A (id) 1997-12-04
AR008761A1 (es) 2000-02-23
ES2166487T3 (es) 2002-04-16
HUP9700989A2 (en) 1997-12-29
ATE209630T1 (de) 2001-12-15
JPH1067731A (ja) 1998-03-10
NO310188B1 (no) 2001-06-05
JP4101904B2 (ja) 2008-06-18
EP0811610B1 (de) 2001-11-28
NO972527L (no) 1997-12-05
CA2206758C (en) 2007-08-14
SK282628B6 (sk) 2002-10-08
CA2206758A1 (en) 1997-12-04
SK69697A3 (en) 1998-01-14
AU723665B2 (en) 2000-08-31
PL320327A1 (en) 1997-12-08
TR199700453A2 (xx) 1997-12-21
PL185757B1 (pl) 2003-07-31
CZ169697A3 (en) 1997-12-17
DE59705495D1 (de) 2002-01-10
DK0811610T3 (da) 2002-03-25
RU2214397C2 (ru) 2003-10-20
BR9703440A (pt) 1998-09-29
ZA974869B (en) 1997-12-04
NO972527D0 (no) 1997-06-03
HU9700989D0 (en) 1997-07-28

Similar Documents

Publication Publication Date Title
IL129315A0 (en) Oxadiazoles process for their preparation and their use as medicaments
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
HUP0001923A3 (en) Pesticidal 1-aryl-3-iminopyrazoles, process for their preparation, their use
GB9715490D0 (en) Pharmaceutical preparation
IL125743A0 (en) A medicinal preparation
EP0907644A4 (en) PHARMACEUTICAL PREPARATION
GB9604736D0 (en) A pharmaceutical preparation
IL120924A0 (en) Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
IL120988A0 (en) Ortho-substituded benzoylguenidines process for their preparation their use as a medicament comprising them
GB9408053D0 (en) Pharmaceutical preparation
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
IL131205A0 (en) Process for preparing pharmaceutical compounds
GB2330144B (en) Process for preparing doxorubicin
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
EP0932601A4 (en) METHOD FOR PRODUCING PHARMACEUTICALS
HU9501546D0 (en) Sulphamide-derivatives, process for their preparation and their use as insecticides
PL319673A1 (en) Biphenoles preparation process
IL128917A0 (en) New heteroaryloxyethylamines a process for the preparation thereof their use as medicaments and pharmaceutical compositions containing them
ZA952013B (en) Pharmaceutical preparation
GB9411842D0 (en) Pharmaceutical preparation
GB9423498D0 (en) Pharmaceutical preparation
PL303622A1 (en) Immunising preparation
GB9420703D0 (en) Medicament
GB9408693D0 (en) Medicament